Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III in Human Plasms and Human Urine Using LC-MS/MS

In this study, we developed and validated an LC-MS/MS method for the simultaneous determination of CP-I and CP-III in human plasma with the lowest LLOQ limit.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

This field is for validation purposes and should be left unchanged.

Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III in Human Plasms and Human Urine Using LC-MS/MS

Resources to Consider

Quantitation of Four Chiral Drug Compounds Simultaneously Using…

Development and Validation of an LC-MS.MS Method for the Simultaneous...

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous...

Simultaneous Quantification Of Total Antibody And...

Validation of a Low-Volume Plasma LC-MS/MS Method Using a...

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...

High Throughput Sample Analysis Using Gyrolab

Preclinical Drug Screening Using Gyrolab

Neurofilament Light Chain: Method Validation of Quantitation Using...

Surrogate Analyte Approaches in Bioanalysis using LC-MS-MS

Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption

Intraperitoneal Dose Administration: Successful Testing Using IP...